These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

756 related articles for article (PubMed ID: 15173053)

  • 21. Randomized trials for the real world: making as few and as reasonable assumptions as possible.
    Baker SG; Kramer BS
    Stat Methods Med Res; 2008 Jun; 17(3):243-52. PubMed ID: 17925312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of futility in clinical trials.
    Snapinn S; Chen MG; Jiang Q; Koutsoukos T
    Pharm Stat; 2006; 5(4):273-81. PubMed ID: 17128426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modification of the sample size and the schedule of interim analyses in survival trials based on data inspections, by H. Schäfer and H.-H. Müller, Statistics in Medicine 2001; 20: 3741-3751.
    Bauer P; Posch M
    Stat Med; 2004 Apr; 23(8):1333-4; author reply 1334-5. PubMed ID: 15083486
    [No Abstract]   [Full Text] [Related]  

  • 24. [The ABC's of medical statistics. Reading and understanding clinical trials].
    Labenz J; Kunz CU
    Anaesthesist; 2011 Jan; 60(1):79-89; quiz 90. PubMed ID: 21264653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obtaining an evidence-base for clinical dentistry through clinical trials.
    Innes NP; Evans DJ; Clarkson JE; Foley JI
    Prim Dent Care; 2005 Jul; 12(3):91-6. PubMed ID: 16004718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sample size estimation: an overview with applications to orthodontic clinical trial designs.
    Pandis N; Polychronopoulou A; Eliades T
    Am J Orthod Dentofacial Orthop; 2011 Oct; 140(4):e141-6. PubMed ID: 21967951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Don't throw out the observation studies with the bath-water. Assess their quality instead].
    Rosén M; Axelsson S; Lindblom J
    Lakartidningen; 2008 Nov 5-11; 105(45):3191-4. PubMed ID: 19062610
    [No Abstract]   [Full Text] [Related]  

  • 28. An examination of the efficiency of the sequential parallel design in psychiatric clinical trials.
    Tamura RN; Huang X
    Clin Trials; 2007; 4(4):309-17. PubMed ID: 17848492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using aspects of study design in sample size estimation.
    Phillips A; Campbell M
    J Biopharm Stat; 1997 May; 7(2):215-26. PubMed ID: 9136065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis strategies for adaptive designs with multiple endpoints.
    Chang M; Chow SC
    J Biopharm Stat; 2007; 17(6):1189-200. PubMed ID: 18027225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and analysis of prostate cancer trials.
    Sylvester R
    Acta Urol Belg; 1994 Apr; 62(1):23-9. PubMed ID: 8197926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Methodological quality assessment of clinical trials in traditional Chinese medicine: the principles of evidence-based medicine].
    Liu JP
    Zhong Xi Yi Jie He Xue Bao; 2006 Jan; 4(1):1-6. PubMed ID: 16409958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal timing for interim analyses in clinical trials.
    Togo K; Iwasaki M
    J Biopharm Stat; 2013; 23(5):1067-80. PubMed ID: 23957516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiplicity adjustment big and small in clinical studies.
    Hsu JC
    Clin Pharmacol Ther; 2010 Aug; 88(2):251-4. PubMed ID: 20592727
    [No Abstract]   [Full Text] [Related]  

  • 35. Statistical inference for clinical trials with binary responses when there is a shift in patient population.
    Yang LY; Chi Y; Chow SC
    J Biopharm Stat; 2011 May; 21(3):437-52. PubMed ID: 21442518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does study design explain the relationship between conflict of interest and positive outcome in clinical trials in psychiatry?
    Wu Y; Deboeck P; Joseph M; Hwang C; Perlis CS; Perlis RH
    J Clin Psychopharmacol; 2009 Dec; 29(6):609-11. PubMed ID: 19910733
    [No Abstract]   [Full Text] [Related]  

  • 37. Assessing the validity of clinical trials.
    Akobeng AK
    J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):277-82. PubMed ID: 18728521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multistage analysis strategy for a clinical trial to assess successively more stringent criteria for a primary endpoint with a low event rate.
    Li S; Hussey MA; Schwartz TA; Koch GG
    Pharm Stat; 2013; 12(2):65-73. PubMed ID: 23424092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can non-randomized trials be considered to be equivalent to randomized trials in forensic mental health?
    Leese M
    Crim Behav Ment Health; 2005; 15(2):121-2. PubMed ID: 16470506
    [No Abstract]   [Full Text] [Related]  

  • 40. Sample size estimation for non-inferiority trials of time-to-event data.
    Crisp A; Curtis P
    Pharm Stat; 2008; 7(4):236-44. PubMed ID: 17583558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.